Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
142.60+0.52 (+0.37%)
At close: 04:03PM EDT
142.35 -0.25 (-0.18%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close142.08
Open141.89
Bid141.20 x 800
Ask142.58 x 1000
Day's Range140.27 - 143.09
52 Week Range105.56 - 175.91
Volume4,902,764
Avg. Volume6,146,751
Market Cap252.131B
Beta (5Y Monthly)0.68
PE Ratio (TTM)20.17
EPS (TTM)7.07
Earnings DateOct 27, 2022 - Oct 31, 2022
Forward Dividend & Yield5.64 (3.96%)
Ex-Dividend DateJul 14, 2022
1y Target Est159.24
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-18% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABBV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AbbVie Inc.
    Analyst Report: AbbVie Inc.AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more
Advertisement
Advertisement